Ubs Oconnor LLC Opiant Pharmaceuticals, Inc. Transaction History

Ubs Oconnor LLC

  • $1.72 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 15, 2019
SELL
$13.84 - $18.79 $76,493 - $103,852
-5,527 Reduced 18.48%
24,373 $352,000
Q3 2018

Nov 14, 2018
BUY
$12.89 - $23.43 $385,411 - $700,557
29,900 New
29,900 $0

Others Institutions Holding OPNT

# of Institutions
2
Shares Held
300
Call Options Held
0
Put Options Held
0
View Full List

About OPIANT PHARMACEUTICALS, INC.

OPNT Quotes by TradingView
  • Ticker OPNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,164,150
  • Description
  • Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...
More about OPNT
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email